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Abstract
BACKGROUND—Serious psychological distress (SPD) is associated with adverse health 
outcomes such as poor quality of life and shorter survival in cancer survivors, but to the authors’ 
knowledge, the relationship between SPD and health care use and medical expenditures is not 
clear.
METHODS—A total of 4326 cancer survivors and 57,109 noncancer participants were identified 
from the 2008 through 2010 Medical Expenditure Panel Survey, a nationwide population-based 
survey, and their psychological distress was assessed with the 6-item Kessler Psychological 
Distress Scale (SPD defined by a score ≥13). The association between SPD and use and medical 
expenditures of various types of health care (office-based, outpatient, hospital inpatient, 
emergency department, dental, and prescriptions) was examined using a 2-part modeling approach 
that adjusted for demographic, personal, and comorbidity factors. The marginal effects of SPD on 
health care use and expenditures were calculated for cancer survivors and were compared with 
those of noncancer participants.
RESULTS—The weighted prevalence of SPD in cancer survivors was 8.2% compared with 4.8% 
in the noncancer participants. SPD was significantly associated with higher use of all care types 
except dental care in cancer survivors. Cancer survivors with SPD spent $4431 (95% confidence 
interval, $3419-$5443) more than survivors without SPD on medical services each year, whereas 
this extra expenditure associated with SPD for participants without cancer was $2685 (95% 
confidence interval, $2099-$3271).
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CONCLUSIONS—In a national representative sample of cancer survivors, SPD was found to be 
associated with higher health care use and medical expenditures. Distress screening and 
psychosocial care in cancer survivors may help reduce the economic burden of cancer in the 
United States.
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INTRODUCTION
Cancer survivors face multiple and often chronic stressors from their diagnosis and 
treatment, such as infertility, cardiac dysfunction, limited employment opportunities, 
difficulty obtaining health insurance, financial limitations, and psychosocial stressors such 
as fear of cancer recurrence.1 As addressed in the Institute of Medicine’s seminal 2008 
report Cancer Care for the Whole Patient: Meeting Psychosocial Health Needs,2 these 
stressors make cancer survivors prone to psychological distress, which is often unrecognized 
and undertreated.1,3 Serious psychological distress (SPD) is manifested by a set of 
behavioral, emotional, cognitive, and psychophysiological symptoms reported at a severe 
level indicative of a high likelihood of diagnosable conditions such as mood or anxiety 
disorders.4,5 With an estimated prevalence of approximately 5% in the general US 
population,6 SPD is associated with several adverse health outcomes such as higher 
mortality and lower quality of life.3,5,7 However, to our knowledge, the relationship between 
psychological distress and health care use and/or medical expenditures has not been 
previously examined among cancer survivors. Insights regarding this relationship will 
inform estimates concerning the economic impact of psychological distress and the potential 
value of distress screening and psychosocial intervention in cancer care.
We used data from the nationally representative Medical Expenditure Panel Survey (MEPS) 
to illuminate this relationship. Our secondary aim was to determine whether the association 
between SPD and health care use/expenditure in cancer survivors is different from that of 
individuals never diagnosed with cancer. In addition to the overall population of cancer 
survivors, we also examined these associations in survivors of the 3 most prevalent cancer 
types: female breast cancer, prostate cancer, and colorectal cancer. Other cancer types were 
not examined separately because of an insufficient number of cases.
MATERIALS AND METHODS
Data Source and Study Sample
The data for the current study were obtained from the respondents to the MEPS Household 
Component survey for 2008 through 2010 who were aged ≥18 years. The MEPS is an 
ongoing household survey cosponsored by the Agency for Healthcare Research and Quality 
and the National Center for Health Statistics of the Centers for Disease Control and 
Prevention. Each year, MEPS collects data from a sample panel of families and individuals 
drawn from households who participated in the prior year’s National Health Interview 
Survey, a nationally representative sample of the US civilian noninstitutionalized 
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population. The panel is followed for 2 years in 5 rounds of in-person interviews with a 
family member who typically responds for all family members in the household. During the 
interview, MEPS collects detailed information regarding demographic characteristics, health 
conditions, health status, use of medical services, charges and source of payments, access to 
care, satisfaction with care, health insurance coverage, income, and employment. At the time 
of completion of the household interview, a sample of medical providers are contacted by 
telephone to obtain information that household respondents cannot accurately provide, and 
the information is used to supplement household-reported information concerning health 
care use and expenditures. Additional information regarding the design and content of 
MEPS can be found elsewhere.8,9
Cancer survivors were identified from a survey question that asked whether a person was 
ever told by a physician or other health professional that he/she had cancer or a malignancy 
of any kind; if the respondent answered yes, follow-up questions were asked regarding 
cancer type and age at the time of diagnosis. Excluding those respondents who only reported 
nonmelanoma skin cancer, there were 5102 records of cancer survivors out of 102,767 
observations in the combined data set for 2008 through 2010. Also excluded were those 
individuals who were missing information regarding psychological distress (N = 634), age at 
cancer diagnosis (N = 97), and/or those respondents for whom cancer was diagnosed after 
psychological distress was measured during the year (N = 45), leaving 4326 cancer 
survivors (including 803 survivors of female breast cancer, 596 survivors of prostate cancer, 
and 285 survivors of colorectal cancer). There were 57,109 records for individuals with no 
record of cancer with known SPD status that were included in the analysis for the secondary 
objective.
Primary Independent Variable
MEPS uses a well-validated and widely used 6-question scale developed by Kessler et al 
(K6)10 to measure psychological distress. The K6 questions were asked at rounds 2 and 4 
through the adult self-administered questionnaire. The K6 includes questions regarding the 
frequency of 6 symptoms (feeling nervous, hopeless, restless or fidgety, so sad that nothing 
could cheer you up, that everything was an effort, and worthless) during the past 30 days. 
Five frequency options are given (none of the time, a little of the time, some of the time, 
most of the time, and all of the time) and scored on a scale of 0 to 4, respectively, such that 
the total score ranges from 0 to 24. SPD is defined as a score of ≥13 as recommended by 
Kessler et al.4 The K6 has been well validated in various populations and has demonstrated 
excellent internal consistency and reliability.11
Outcome Variables
We examined 7 categories of health services use using the following outcomes: the number 
of office-based medical provider visits (not including medical care provided in other settings 
such as a hospital, nursing home, or an individual’s home), the number of hospital outpatient 
visits, the number of hospital inpatient discharges, the number of emergency department 
visits, the number of dental visits, the number of home health care visits, and the number of 
prescribed medicines. We also examined the medical expenditures for the above 7 categories 
as well as the total medical expenditure.
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The following variables were reported during the interview and were recoded when needed 
according to the distribution of the cancer survivors in this analysis: age (18-54 years, 55-64 
years, 65-74 years, 75-84 years, and ≥85 years), race/ethnicity (non-Hispanic white, non-
Hispanic black, Hispanic, and other), sex, education level (<high school, high school 
graduate, some college, and ≥college graduate), marital status (married or not), poverty 
status (defined by the family income as a percentage of the poverty line, coded as poor/
negative [<100%], near poor [100% to <125%], low [125% to <200%], medium [200% to 
<400%], and high [≥400%]), region (North-east, Midwest, South, and West), health 
insurance status (any private, public only, and uninsured), body mass index (BMI) (<18.5 
kg/m2, 18.5-24.9 kg/m2, 25-29.9 kg/m2, and ≥30 kg/m2), current smoking status (yes vs no), 
current physical activity (yes/no moderate or vigorous physical activity 3 times per week), 
the history of 13 common chronic conditions (coronary heart disease, angina, myocardial 
infarction, other unspecified heart disease, hypertension, stroke, emphysema, chronic 
bronchitis, high cholesterol, diabetes, arthritis, asthma, and attention deficit hyperactivity 
disorder/attention deficit disorder).12 We used the chronic condition information to calculate 
and group the number of comorbid illnesses (0, 1, 2, and ≥3). We calculated the time since 
cancer diagnosis by subtracting the reported age at the time of the cancer diagnosis from the 
age at the time of the survey.
Statistical Analysis
Descriptive analyses were conducted to characterize the cancer survivors and noncancer 
participants by SPD status. Weighted percentages for all demographic and clinical factors 
were calculated, and Wald chi-square tests were used to compare the differences between 
participants with SPD and those without SPD. Next, we calculated the weighted percentages 
of participants who had any health care use and medical expenditures in the 7 categories and 
compared these percentages between SPD status groups using Wald chi-square tests.
For each of the outcome variables, we used a 2-part modeling13,14 approach with a logistic 
regression in part 1 and Poisson regression (for health use variables) or generalized gamma 
regression with log link (for medical expenditure variables) in part 2 to account for the 0 
values in the use and expenditures data. The predicted probability of incurring any health 
care use or expenditure from part 1 and the estimated effect of SPD status on health care use 
or expenditure were multiplied to produce each person’s expected health care use or 
expenditures. Weighted marginal effects of SPD on health care use and expenditures were 
estimated for individuals who were never diagnosed with cancer, cancer survivors overall, 
and survivors of the 3 most prevalent types of cancer. The models were adjusted for the 
following factors: age, race/ethnicity, sex, marital status, poverty status, health insurance 
status, BMI, smoking, physical activity, and number of comorbid conditions. These potential 
confounders were selected based on previous literature concerning risk factors of 
psychological distress15,16 and determinants of medical care use according to the model 
developed by Andersen and Newman.17
To assess the potential confounding from intensive treatment during the first 2 years after a 
cancer diagnosis, we conducted a sensitivity analysis excluding those cancer survivors who 
Han et al. Page 4













were diagnosed <2 years before the survey, and the findings did not change. Many patients 
with breast cancer undergo hormonal therapy for years after the end of primary treatment. 
Certain survivors of prostate cancer also receive hormonal therapy as part of cancer 
treatment and palliative care. To access the potential confounding effect from hormonal 
therapy on the association between psychological distress and prescription use and 
expenditures, we performed a sensitivity analysis in which patients with breast cancer and 
patients with prostate cancer who were diagnosed within 10 years (ie, those survivors most 
likely to be receiving hormonal therapy) were excluded, and the findings did not change.
Finally, we estimated the annual excess cost associated with SPD among cancer survivors in 
the United States by multiplying the estimated extra expenditure per cancer survivor 
associated with SPD and the weighted number of cancer survivors with SPD in this 
nationwide sample.
STATA statistical software (version 12.1; StataCorp, College Station, Tex) was used for the 
2-part model analysis, and SAS statistical software (version 9.3; SAS Institute Inc, Cary, 
NC) was used in all other analyses.
RESULTS
The characteristics of survey respondents by cancer status and SPD status are reported in 
Table 1. The weighted prevalence of SPD and its 95% confidence interval (95% CI) were 
5.1% (95% CI, 4.8%-5.4%) in all participants, 8.2% (95% CI, 7.1%-9.3%) in the subset of 
cancer survivors, and 4.8% (95% CI, 4.6%-5.1%) in participants never diagnosed with 
cancer. Regardless of cancer status, individuals with SPD tended to be less educated and 
poorer; were more likely to be female, unmarried, obese, physically inactive, and a smoker; 
reported ≥3 comorbid illnesses; and were less likely to have private health insurance (Table 
1). Cancer survivors with SPD also tended to be younger than survivors without SPD (Table 
1).
Regardless of SPD status, approximately 98% of cancer survivors had some medical 
expenditure during the year; among noncancer participants, 83% of those without SPD and 
91% of those with SPD had some medical expenditures (Table 2). When each type of health 
care was examined individually, those survivors with SPD were found to have a higher 
frequency of any use/expenditure for most types of health care services except office-based 
and dental care, compared with cancer survivors without SPD.
In cancer survivors overall, SPD was associated with higher health care use of every service 
type, with each association being statistically significant except for dental care after 
adjustment for demographic, medical, and behavioral confounders (Fig. 1). The magnitude 
of the association did not differ significantly for the 3 common cancer types. We also found 
that for the noncancer participants in the survey, SPD was similarly significantly associated 
with higher use of office-based care, hospital outpatient care, hospital inpatient care, and 
emergency department visits. However, we observed that the marginal effects of SPD on the 
number of prescriptions were notably larger in cancer survivors compared with noncancer 
participants (9.7 vs 6.3) (Fig. 1). The frequency of home health care use was too small for 
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estimation, and therefore is not shown on the graphs. For medical expenditures, after 
adjusting for confounders, cancer survivors spent an average of $7927 each year and 
noncancer participants spent an average of $3972 each year. Cancer survivors with SPD 
spent $4431 (95% CI, $3419-$5443) more than those without SPD every year, whereas 
among noncancer participants, the extra expenditure associated with SPD was $2685 (95% 
CI, $2099-$3271) per year (Fig. 2). Regardless of cancer status, individuals with SPD spent 
more than those without SPD in every care type, and this was found to be statistically 
significant for the use of office-based providers and for prescriptions (Fig. 2). There were no 
variations evident among survivors of the 3 most common cancer types.
Finally, by multiplying the estimated extra expenditure associated with SPD among cancer 
survivors ($4431) and the weighted number of cancer survivors with SPD in the United 
States (1,467,020), we estimated that cancer survivors with SPD spent an additional $6.5 
billion in health care annually.
DISCUSSION
In this nationally representative sample of noninstitutionalized US adults conducted between 
2008 and 2010, the prevalence of SPD was 5.1% for general participants and 8.2% for 
cancer survivors. These estimates are consistent with other recent studies of the general US 
population6 and cancer survivors,18,19 although they are both slightly higher than the 
estimates obtained from data of earlier years.16,20-22 Using this population-based national 
sample, the current study illustrates for what we believe to be the first time the association 
between psychological distress and health care use and medical expenditure by service type 
among cancer survivors. We found that SPD was significantly associated with higher use of 
almost all types of heath care except dental care, as well as higher total medical 
expenditures, office-based expenditures, and prescription expenditures in cancer survivors. 
Although the same association was also identified in noncancer participants, the increase in 
prescription and total expenditures associated with SPD was notably larger in cancer 
survivors compared with noncancer participants.
Examining the comparisons for each care type further (Fig. 2), we found that the main 
contributors to the greater effects of SPD on total expenditures noted among cancer 
survivors were office-based care expenditures and prescription expenditures, suggesting that 
cancer survivors with SPD may be particularly in need of these 2 types of services. In the 
general population, the higher physician visit and prescription expenditures associated with 
SPD may be attributable to increased mental health visits and medication use,6 whereas 
cancer survivors with SPD may not only have higher mental health visit and medication 
expenditures, but also higher rates of cancer-related physician visits and prescriptions 
compared with survivors without SPD. This synergic effect of cancer and SPD may partly 
explain the stronger association observed between SPD and health care use/expenditures for 
cancer survivors compared with noncancer controls.
Although psychosocial care is recognized as an essential part of quality cancer care,23,24 
reports and guidelines supporting psychosocial care are based on the strong evidence that 
psychosocial stress is adversely associated with multiple health outcomes such as quality of 
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life, symptoms, health behaviors, and survival.3,25 The results of the current study further 
suggest that addressing psychosocial needs may not only improve the quality of cancer care 
but also may reduce the economic and service burden of cancer to society. We estimated 
that an excess of $6.5 billion associated with SPD among cancer survivors was spent by the 
nation annually. Although the current study was a cross-sectional survey, the findings 
regarding the association between SPD and increased health care use and medical 
expenditures suggest that interventions to reduce SPD could have economic benefits. This is 
supported by several cost-effectiveness studies of psychosocial interventions in cancer 
care.26,27 However, despite the growing public and professional awareness of the 
importance of psychosocial care, basic conversations regarding psychological concerns have 
yet to be adequately addressed. A recent survey conducted by the American Psychosocial 
Oncology Society found that routine screening for distress was not offered in a majority of 
cancer care organizations despite the recommendations of the Institute of Medicine and the 
National Comprehensive Cancer Network.28 Another recent study with a nationwide 
population-based sample of 1777 cancer survivors demonstrated that the majority of 
survivors reported neither provider discussion nor the use of professional counseling or 
support groups.29 Screening and early psychological intervention for distress may improve 
quality of life and mitigate both the symptoms and increased health care expenditures 
associated with comorbid psychiatric conditions such as depression and anxiety.30,31 
Furthermore, given the projected imbalance between the demand for and supply of oncology 
services for cancer survivors and shortages of primary care providers,32 it is important to 
maximize the efficiency and efficacy of follow-up care with the limited workforce and to 
understand the pattern of health care use related to psychosocial distress. Another way of 
promoting efficient yet appropriate survivorship care is risk-stratified care, in which the care 
provider and frequency of follow-up depend on patient needs and health risks.33,34 The 
finding in the current study that SPD is associated with higher health care use and medical 
expenditures suggests that psychological distress may be an important factor to consider in 
the risk stratification, although more work is needed to fully understand how to stratify 
survivors to ensure appropriate, comprehensive, and sustainable survivorship care.
The current study was subject to several limitations. First, no causal relationship can be 
inferred given the cross-sectional study design, although it is useful in estimating the 
economic burden of SPD in cancer survivors. In addition, MEPS does not collect data 
regarding cancer stage and severity, type of cancer treatment, or cancer recurrence, variables 
that could influence SPD and health care use. The sample size for many cancer sites was 
small, reflecting the prevalence of different cancer types in the population, and therefore we 
were only able to examine subgroup differences for the 3 largest groups: breast, prostate, 
and colorectal cancer survivors. There is a possibility that the association between SPD and 
health care use is confounded by additional variables such as comorbid medical conditions 
or general health status. We attempted to minimize potential confounding by controlling for 
the number of comorbid conditions in the analysis as well as BMI, smoking status, and 
physical activity, variables that could be associated with both psychological distress and 
health care use. However, a more in-depth assessment of confounding requires longitudinal 
data and should be evaluated in future studies. Note that the findings of the current study 
regarding the associations between SPD and health care use and expenditures do not inform 
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us about the relationship between specific psychiatric conditions and health care use and 
expenditures as typically examined in the literature,30,31 yet the results of the current study 
provide insights into the medical expenditures associated with more global signs of 
psychological distress that may be common in real-world clinical settings. Nevertheless, we 
believe the current study contributes to the field with its unique strengths: it is nationally 
representative, it includes adult cancer survivors of all ages; it provides comparison with 
individuals without cancer; and the expenditures were from all payers, including out-of-
pocket expenses incurred by patients.
SPD in cancer survivors is significantly associated with the higher use of office-based care, 
outpatient care, inpatient care, emergency department, and more prescriptions, as well as 
total medical expenditures. The results of the current study suggest that integrating 
psychosocial support in cancer care has the potential to reduce the economic burden of 
cancer. Moving forward, research is needed to identify models of cancer care delivery that 
address SPD and optimize psychosocial functioning at different phases of survivorship and 
among various subgroups. In addition, future studies may collect data regarding the range of 
costs and benefits associated with different models of care to inform health care providers, 
payers, and other individuals who are involved in making decisions concerning the delivery 
of cancer treatment and follow-up care.
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Marginal effects of serious psychological distress status on health care use are shown from 
the Medical Expenditure Panel Survey (MEPS), 2008 to 2010.
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Marginal effects of serious psychological distress status on medical expenditures are shown 
from the Medical Expenditure Panel Survey (MEPS), 2008 to 2010.
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